See more : ANZ Group Holdings Limited (ANZ.NZ) Income Statement Analysis – Financial Results
Complete financial analysis of Nano-X Imaging Ltd. (NNOX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nano-X Imaging Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- E79 Gold Mines Limited (E79.AX) Income Statement Analysis – Financial Results
- KFin Technologies Limited (KFINTECH.BO) Income Statement Analysis – Financial Results
- Deveron Corp. (FARM.V) Income Statement Analysis – Financial Results
- Tohoku Chemical Co., Ltd. (7446.T) Income Statement Analysis – Financial Results
- Cigna Corporation (CI) Income Statement Analysis – Financial Results
Nano-X Imaging Ltd. (NNOX)
About Nano-X Imaging Ltd.
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.91M | 8.58M | 1.30M | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 16.50M | 15.46M | 2.82M | 208.00K | 53.00K | 35.00K |
| Gross Profit | -6.59M | -6.88M | -1.51M | -208.00K | -53.00K | -35.00K |
| Gross Profit Ratio | -66.55% | -80.21% | -115.95% | 0.00% | 0.00% | 0.00% |
| Research & Development | 26.05M | 26.51M | 17.12M | 9.21M | 2.72M | 672.00K |
| General & Administrative | 26.01M | 41.25M | 34.71M | 22.27M | 18.30M | 1.02M |
| Selling & Marketing | 2.38M | 4.38M | 7.03M | 12.45M | 1.56M | 209.00K |
| SG&A | 28.39M | 45.63M | 41.74M | 34.71M | 19.85M | 1.23M |
| Other Expenses | 1.55M | 191.00K | 1.18M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 56.00M | 72.33M | 60.05M | 43.92M | 22.57M | 1.90M |
| Cost & Expenses | 72.49M | 87.79M | 62.86M | 43.92M | 22.57M | 1.90M |
| Interest Income | 1.65M | 789.00K | 288.00K | 108.00K | 8.00K | 0.00 |
| Interest Expense | 0.00 | 60.22M | 288.00K | 0.00 | 0.00 | 5.00K |
| Depreciation & Amortization | 11.81M | 11.51M | 2.29M | 208.00K | 53.00K | 35.00K |
| EBITDA | -47.69M | -75.70M | -59.27M | -43.61M | -22.52M | -1.87M |
| EBITDA Ratio | -481.50% | -433.60% | -4,720.71% | 0.00% | 0.00% | 0.00% |
| Operating Income | -62.59M | -109.71M | -61.56M | -43.92M | -22.57M | -1.90M |
| Operating Income Ratio | -631.89% | -1,278.97% | -4,720.71% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.47M | -14.67M | -288.00K | 108.00K | 8.00K | -5.00K |
| Income Before Tax | -61.12M | -108.92M | -61.85M | -43.82M | -22.56M | -1.91M |
| Income Before Tax Ratio | -617.01% | -1,269.77% | -4,742.79% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -339.00K | -3.68M | -48.00K | -316.00K | -8.00K | 5.00K |
| Net Income | -60.78M | -105.24M | -61.80M | -43.50M | -22.56M | -1.91M |
| Net Income Ratio | -613.59% | -1,226.89% | -4,739.11% | 0.00% | 0.00% | 0.00% |
| EPS | -1.08 | -2.01 | -1.28 | -1.22 | -0.49 | -0.06 |
| EPS Diluted | -1.08 | -2.01 | -1.28 | -1.22 | -0.49 | -0.06 |
| Weighted Avg Shares Out | 56.37M | 52.24M | 48.22M | 35.65M | 45.72M | 34.17M |
| Weighted Avg Shares Out (Dil) | 56.37M | 52.24M | 48.22M | 35.65M | 45.72M | 34.17M |
Nanox to Report Third Quarter 2023 Financial Results on November 28, 2023 and Reschedules Investor Day for December 4, 2023
Nanox Continues Business as Planned, and Postpones Investor Day Scheduled for October 17, 2023
Nanox Announces Strategic Manufacturing Agreement with Varex Imaging Corporation to Advance the Nanox.ARC Medical Imaging System
Israeli's Nano-X settles US SEC charges over costs of flagship imaging device
Nanox.AI's HealthCCSng AI Solution Reveals ~60% of Patients in Study had Previously Undetected Risk of a Cardiovascular Event from Routine Chest CTs
Ticking Time Bombs: 3 Biotech Stocks to Dump Before the Damage Is Done
Nanox to Present at the Cantor Fitzgerald Global Healthcare Conference 2023 in September
3 Magnificent Growth Stocks to Buy on the Dip
Nano-X Imaging Ltd (NNOX) Q2 2023 Earnings Call Transcript
Nanox Announces Second Quarter of 2023 Financial Results and Provides Business Update
Source: https://incomestatements.info
Category: Stock Reports